"Labetalol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
Descriptor ID |
D007741
|
MeSH Number(s) |
D02.033.100.291.460 D02.065.793.324 D02.092.063.291.460
|
Concept/Terms |
Dilevalol- Dilevalol
- Labetalol, (R,R)-Isomer
- R,R-Labetalol
- R,R Labetalol
|
Below are MeSH descriptors whose meaning is more general than "Labetalol".
Below are MeSH descriptors whose meaning is more specific than "Labetalol".
This graph shows the total number of publications written about "Labetalol" by people in this website by year, and whether "Labetalol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2014 | 1 | 1 | 2 |
2015 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Labetalol" by people in Profiles.
-
Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension. Obstet Gynecol. 2024 Jul 01; 144(1):126-134.
-
Does Labetalol Trigger False Positive Drug Testing Results? J Addict Med. 2023 May-Jun 01; 17(3):e209-e210.
-
Gestational weight gain among gravidae with hypertension receiving labetalol versus nifedipine. Pregnancy Hypertens. 2022 06; 28:121-122.
-
Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure. Am J Obstet Gynecol. 2020 09; 223(3):441.e1-441.e8.
-
Characteristics of patients that do not initially respond to intravenous antihypertensives in the emergency department: subanalysis of the CLUE trial. West J Emerg Med. 2015 Mar; 16(2):276-83.
-
The management of acute hypertension in patients with renal dysfunction: labetalol or nicardipine? Postgrad Med. 2014 Jul; 126(4):124-30.
-
Impact of initial blood pressure on antihypertensive response in patients with acute hypertension. Am J Emerg Med. 2014 Aug; 32(8):833-6.
-
A systematic review of nicardipine vs labetalol for the management of hypertensive crises. Am J Emerg Med. 2012 Jul; 30(6):981-93.
-
CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department. Crit Care. 2011; 15(3):R157.
-
Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr Crit Care Med. 2011 Jan; 12(1):28-32.